Luqmaan Khan, who was born in Pakistan and is now a US citizen, was arrested shortly before midnight on November 24 after officers found him inside his pickup truck at Canby Park West after closing ...

WASHINGTON — D.C. homeless people, an international invasion, kidnapping and murder. These were the center of a plot prosecutors say was thought up by two Texas men — landing them in jail and facing ...

Two twisted Texans allegedly planned to invade a small Haitian island with an army of homeless people — to kill all the men so they could enslave the women and kids as “their sex slaves,” according to ...

PLANO, Texas (KSLA) - Two men from north Texas have been indicted for an alleged plot to invade an island off Haiti, murder the men there, and use the women and children as sex slaves, says U.S.

Two North Texas men were indicted this week after federal authorities said they conspired to “invade” Haiti. According to a news release from the U.S. Attorney’s office for the Eastern District of ...

Jeff Bezos’ Blue Origin (BORGN) on Thursday unveiled a sweeping set of upgrades to its New Glenn launch system, aiming to significantly increase payload capacity, launch cadence and vehicle ...

Avengers Doomsday plot leak rumor that goes over the origin of Doctor Doom in the MCU. This Doomsday leak ties the main Victor Von Doom in Avengers Doomsday to be a variant of Tony Stark from the main ...

Enayet Karim Chowdhury, a US citizen of Bangladeshi origin, was sent to jail yesterday (13 September) after being arrested for suspicious movements and alleged conspiracy to overthrow the interim ...

When Tim Cook takes center stage next week to show off the latest iPhones, he is trumpeting the future of a company that’s been severely weakened from just a few years ago.

Blue Origin and Anduril have landed new study contracts with the U.S. Air Force to explore how their technology, including rockets, could move military cargo around the world. The contracts under the ...

MapLight Therapeutics has raised a $372.5 million series D round, clearing the biotech to chart a course through phase 2 for its would-be challenger to Bristol Myers Squibb’s schizophrenia treatment ...